NextCure

NXTCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$21.095 M

$5.84 +4.47%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$55.8M

Loss-making

Shares outstanding

4,577,359

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#391Allarity TherapeuticsALLR$21.5M
#392CalciMedicaCALC$21.1M
#393NextCureNXTC$21.1M
#394Dare BioscienceDARE$21.0M
#395Neuphoria TherapeuticsNEUP$20.6M

Where these numbers come from

Share counts and financials for NextCure are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.